FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

116551004: Phenyltoloxamine citrate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
203177017 Phenyltoloxamine citrate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
679589015 Phenyltoloxamine citrate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
23311000188113 phényltoloxamine citrate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
833271000172110 citrate de phényltoloxamine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Phenyltoloxamine citrate Is a Ethanolamine derivative histamine receptor antagonist product false Inferred relationship Some
Phenyltoloxamine citrate Is a Sedating antihistamine false Inferred relationship Some
Phenyltoloxamine citrate Is a Phenyltoloxamine (substance) false Inferred relationship Some
Phenyltoloxamine citrate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Histamine receptor antagonist (disposition) true Inferred relationship Some
Phenyltoloxamine citrate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Phenyltoloxamine (substance) true Inferred relationship Some
Phenyltoloxamine citrate Is a Ethanolamine derivative antihistamine true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate 4mg/20mg/50mg m/r capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenyltoloxamine citrate Inferred relationship Some
Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate 2.5mg/5mL 5mg/5mL 7.5mg/5mL liquid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenyltoloxamine citrate Inferred relationship Some
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenyltoloxamine citrate Inferred relationship Some
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenyltoloxamine citrate Inferred relationship Some
Acetaminophen + phenyltoloxamine citrate 500mg/30mg caplets The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenyltoloxamine citrate Inferred relationship Some
Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenyltoloxamine citrate Inferred relationship Some
Paracetamol 500 mg and phenyltoloxamine citrate 60 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenyltoloxamine citrate Inferred relationship Some
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenyltoloxamine citrate Inferred relationship Some
Product containing paracetamol and phenyltoloxamine citrate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenyltoloxamine citrate Inferred relationship Some
Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenyltoloxamine citrate Inferred relationship Some
Product containing paracetamol and phenyltoloxamine citrate and salicylamide The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenyltoloxamine citrate Inferred relationship Some
Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenyltoloxamine citrate Inferred relationship Some 1
Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Phenyltoloxamine citrate Inferred relationship Some 1
Paracetamol 500 mg and phenyltoloxamine citrate 60 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenyltoloxamine citrate Inferred relationship Some 2
Paracetamol 500 mg and phenyltoloxamine citrate 60 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Phenyltoloxamine citrate Inferred relationship Some 2
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Phenyltoloxamine citrate Inferred relationship Some 2
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenyltoloxamine citrate Inferred relationship Some 3
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Phenyltoloxamine citrate Inferred relationship Some 3
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenyltoloxamine citrate Inferred relationship Some 1
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Phenyltoloxamine citrate Inferred relationship Some 1
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Phenyltoloxamine citrate Inferred relationship Some 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenyltoloxamine citrate Inferred relationship Some 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Phenyltoloxamine citrate Inferred relationship Some 2
Paracetamol 500 mg and phenyltoloxamine citrate 30 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Phenyltoloxamine citrate Inferred relationship Some 2
Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Phenyltoloxamine citrate Inferred relationship Some 1
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Phenyltoloxamine citrate Inferred relationship Some 2
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Phenyltoloxamine citrate Inferred relationship Some 2
Paracetamol 500 mg and phenyltoloxamine citrate 60 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Phenyltoloxamine citrate Inferred relationship Some 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Phenyltoloxamine citrate Inferred relationship Some 2
Paracetamol 500 mg and phenyltoloxamine citrate 30 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Phenyltoloxamine citrate Inferred relationship Some 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Phenyltoloxamine citrate Inferred relationship Some 1
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Phenyltoloxamine citrate Inferred relationship Some 1
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Phenyltoloxamine citrate Inferred relationship Some 1
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Phenyltoloxamine citrate Inferred relationship Some 1
Paracetamol 500 mg and phenyltoloxamine citrate 60 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Phenyltoloxamine citrate Inferred relationship Some 1
Paracetamol 500 mg and phenyltoloxamine citrate 60 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Phenyltoloxamine citrate Inferred relationship Some 1
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Phenyltoloxamine citrate Inferred relationship Some 1
Paracetamol 500 mg and phenyltoloxamine citrate 30 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Phenyltoloxamine citrate Inferred relationship Some 1
Paracetamol 500 mg and phenyltoloxamine citrate 30 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Phenyltoloxamine citrate Inferred relationship Some 1

This concept is not in any reference sets

Back to Start